CANSINOBIO

6185
23.3401.85% ( -0.440 )
Delay Closed: Nov 16, 16:08:11

Profile

About

CANSINOBIO
CANSINOBIO
06185.HK

CanSino Biologics Inc. develops, manufactures, and commercializes vaccines in the People’s Republic of China. The company develops Ad5-nCoV for Inhalation vaccines to recombinant novel coronavirus disease; Ad5-EBOV, an Ebola virus vaccine; and MCV2 and MCV4 vaccines for the prevention of N. meningitides.

Profile

Company Name
CanSino Biologics Inc.
Market
SEHK
Founded
Industry
--
Fiscal Year End
December 31

Related Securities

Industry

Management